Biotechnology Value Fund II LP filed Form 3
- Filed on 2026-10-05
- Owns 4,494,462 common shares
- Holds 5,840,979 pre-funded warrants
BIOTECHNOLOGY VALUE FUND L P · BVF PARTNERS L P/IL · +8 more
FHTX
Foghorn Therapeutics Inc. SEC filings
Every EDGAR filing for Foghorn Therapeutics Inc. (FHTX), newest first, with AI summaries and stories.
- Ticker
- FHTX
- CIK
- 1822462
- Sector
- Biotech and pharma
- Latest filing
- Oct 5
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 16)
Filings
3Foghorn Therapeutics Inc.FHTXLIVE SCHEDULE 13G/AFoghorn Therapeutics Inc.FHTXLIVE Foghorn Therapeutics Inc. 14.3% stake held by BVF Partners
- BVF Partners L.P. holds 8,507,000 shares (14.3%)
- BVF Inc. holds 8,507,000 shares (14.3%)
- Mark N. Lampert holds 8,507,000 shares (14.3%)
BIOTECHNOLOGY VALUE FUND L P
8-KFoghorn Therapeutics Inc.FHTXLIVE 10-QFoghorn Therapeutics Inc.FHTXLIVE 8-KFoghorn Therapeutics Inc.FHTXLIVE 4Foghorn Therapeutics Inc.FHTXLIVE 9 insider filings
Stuart Duty, insider filing for FHTX
Show all 9
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
Stuart Duty, reporting
8-KFoghorn Therapeutics Inc.FHTXLIVE SCHEDULE 13G/AFoghorn Therapeutics Inc.FHTXLIVE Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)
BIOTECHNOLOGY VALUE FUND L P, filed by
SCHEDULE 13G/AFoghorn Therapeutics Inc.FHTXLIVE Ownership stake disclosure by James E Flynn (amended)
James E Flynn, filed by
10-QFoghorn Therapeutics Inc.FHTXLIVE 8-KFoghorn Therapeutics Inc.FHTXLIVE SCHEDULE 13G/AFoghorn Therapeutics Inc.FHTXLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ARSFoghorn Therapeutics Inc.FHTXLIVE DEFA14AFoghorn Therapeutics Inc.FHTXLIVE DEF 14AFoghorn Therapeutics Inc.FHTXLIVE 8-KFoghorn Therapeutics Inc.FHTXLIVE 4Foghorn Therapeutics Inc.FHTXLIVE Adrian Gottschalk, insider filing for FHTX
Adrian Gottschalk, reporting
S-8Foghorn Therapeutics Inc.FHTXLIVE 10-KFoghorn Therapeutics Inc.FHTXLIVE 8-KFoghorn Therapeutics Inc.FHTXLIVE 4Foghorn Therapeutics Inc.FHTXLIVE 2 insider filings
Ryan D Maynard, insider filing for FHTX
Show all 2
- 4Insider filing for FHTX
- 3New insider at FHTX
Ryan D Maynard, reporting
8-KFoghorn Therapeutics Inc.FHTXLIVE 4Foghorn Therapeutics Inc.FHTXLIVE Adrian Gottschalk, insider filing for FHTX
Adrian Gottschalk, reporting
4Foghorn Therapeutics Inc.FHTXLIVE 5 insider filings
Carlos Costa, insider filing for FHTX
Show all 5
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
- 4Insider filing for FHTX
Carlos Costa, reporting
4Foghorn Therapeutics Inc.FHTXLIVE Noubar Afeyan, insider filing for FHTX
Noubar Afeyan, reporting · Flagship Pioneering, LLC, reporting · +8 more
SCHEDULE 13D/AFoghorn Therapeutics Inc.FHTXLIVE Ownership stake disclosure by Flagship Ventures Fund V, L.P. (amended)
Flagship Ventures Fund V, L.P., filed by
424B5Foghorn Therapeutics Inc.FHTXLIVE 8-KFoghorn Therapeutics Inc.FHTXLIVE 8-KFoghorn Therapeutics Inc.FHTXLIVE 8-KFoghorn Therapeutics Inc.FHTXLIVE 10-QFoghorn Therapeutics Inc.FHTXLIVE 8-KFoghorn Therapeutics Inc.FHTXLIVE